Skip to main content
. 2018 Apr 9;2018(4):CD007606. doi: 10.1002/14651858.CD007606.pub4

3.12. Analysis.

Comparison 3 Glucocorticosteroid avoidance or withdrawal versus glucocorticosteroid‐containing immunosuppression (antiproliferative subgroups), Outcome 12 Hypertension.